Jeff Stephens
Fondatore presso Infusion 51A LP
Profilo
Jeff Stephens is the founder of Infusion 51A LP, where he holds the title of Managing Partner starting in 2015.
He is also the founder of Camp Athlete, Inc. Jeff's current job is as the Chief Executive Officer at International Infusion LP.
He is also the Managing Partner at International Infusion Advisors LLC, a position he has held since 2009.
Additionally, Jeff is the Chief Executive Officer at International Infusion, Inc. Jeff's former positions include Director at Theralink Technologies, Inc. (Colorado) and Director at Vivacitas Oncology, Inc. Jeff received his undergraduate degree from the University of Southern Indiana.
Posizioni attive di Jeff Stephens
| Società | Posizione | Inizio |
|---|---|---|
International Infusion Advisors LLC
 International Infusion Advisors LLC Investment ManagersFinance International Infusion Advisors LLC provides investment advisory services. The private company is based in Chicago. | Corporate Officer/Principal | 01/01/2009 |
Camp Athlete, Inc.
 Camp Athlete, Inc. Movies/EntertainmentConsumer Services Camp Athlete, Inc. provides sports related services. The private company is based in Chicago. The American company was founded by Jeff Stephens. | Fondatore | - |
| Infusion 51A LP | Fondatore | 01/01/2015 |
| International Infusion, Inc. | Amministratore Delegato | 01/01/2009 |
| International Infusion LP | Amministratore Delegato | - |
Precedenti posizioni note di Jeff Stephens
| Società | Posizione | Fine |
|---|---|---|
Vivacitas Oncology, Inc.
 Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Direttore/Membro del Consiglio | - |
| AVANT DIAGNOSTICS INC | Direttore/Membro del Consiglio | - |
Formazione di Jeff Stephens
| University of Southern Indiana | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
| Infusion 51A LP | Miscellaneous |
International Infusion Advisors LLC
International Infusion Advisors LLC Investment ManagersFinance International Infusion Advisors LLC provides investment advisory services. The private company is based in Chicago. | Finance |
Camp Athlete, Inc.
Camp Athlete, Inc. Movies/EntertainmentConsumer Services Camp Athlete, Inc. provides sports related services. The private company is based in Chicago. The American company was founded by Jeff Stephens. | Consumer Services |
| International Infusion, Inc. | |
| International Infusion LP | |
Vivacitas Oncology, Inc.
Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Health Services |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Borsa valori
- Insiders
- Jeff Stephens
